TMED3 has also been proposed as a potential therapeutic target for the treatment of chordoma, a rare low-grade bone axis tumor; downregulation of TMED3 expression decreased chordoma cell survival and migration and increased apoptosis81. This evidence concerns the gene TMED3 and chordoma.